Abdollahi, A., Favata, M., Weber, M., Roman, V., Hess, R., Hammond, K., Farren, M. R., Schaffer, M., Gilmartin, A., Wang, H., Rios-Doria, J., Amador-Arjona, A. (2025). The FGFR inhibitor pemigatinib overcomes cancer drug resistance to KRAS G12C inhibitors in mesenchymal lung cancer. PLoS ONE. https://doi.org/10.1371/journal.pone.0327588